The Effect of Melatonin on Endometrial Histology in Patients with Endometrial Proliferative Disorders: A Double-Blind Randomized Clinical Trial
A clinical trial found that adding melatonin to progestin treatment for endometrial hyperplasia significantly increased the rate of normal biopsy results after three months.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This double-blind, randomized clinical trial at Al-Zahra Hospital studied whether adding melatonin to progestin improves endometrial histology in 40 women with abnormal vaginal bleeding diagnosed with endometrial proliferative disorders or non-atypical hyperplasia. Participants received 80 mg megestrol acetate daily either alone (control) or with 5 mg melatonin before bedtime for three months (intervention), followed by endometrial biopsy, with groups balanced for demographic factors such as age, gravidity, parity, and BMI. After treatment, normal biopsy results were more frequent with melatonin plus megestrol acetate than with megestrol alone (94.7% vs 66.6%, P<0.05). The main limitation explicitly reflected in the report is the modest sample size and that only 37 of 40 were included in the final analysis. This paper is centrally about endometriosis — it does not explicitly discuss endometriosis, but it is included in the corpus via a keyword match in the upstream search index.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (30)
- Cyclic versus continuous medroxyprogesterone acetate for treatment of endometrial hyperplasia without atypia: a 2-year observational study via openalex
- Efficacy of melatonin in the treatment of endometriosis: A phase II, randomized, double-blind, placebo-controlled trial via openalex
- Factors influencing endometrial thickness in postmenopausal women via openalex
- Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation via openalex
- Melatonin activity and receptor expression in endometrial tissue and endometriosis via openalex
- W2089066699 via openalex
- W2090740247 via openalex
- W2105864875 via openalex
- W2131278010 via openalex
- W2133751283 via openalex
- W2139088926 via openalex
- W2142140707 via openalex
- W2142482195 via openalex
- W2150123539 via openalex
- W2160945331 via openalex
- W2163195447 via openalex
- W2163789824 via openalex
- W2163976491 via openalex
- W2781525129 via openalex
- W2898538969 via openalex
- W3046633455 via openalex
- W3091531645 via openalex
- W4205232656 via openalex
- W4205512358 via openalex
- W4283514853 via openalex
- W4404071941 via openalex
- W2032779870 via openalex
- W2035747244 via openalex
- W2071533148 via openalex
- W2083193550 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00